Kinetics of tumor necrosis factor α in plasma and the cardioprotective effect of a monoclonal antibody to tumor necrosis factor α in acute myocardial infarction

American Heart Journal

Volumn 137, Issue 6, 1999, Pages 1145-1152

  Li, Dayuan ^b   Zhao, Li ^b   Liu, Meilin ^b   Du, Xueping ^b   Ding, Wenhui ^b   Zhang, Junhua ^b   Mehta, Jawahar L ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE MB; MALONALDEHYDE; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ACUTE HEART INFARCTION; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HEART INFARCTION SIZE; HEART MUSCLE NECROSIS; HEART PROTECTION; HUMAN; INFLAMMATION; KINETICS; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0033427325     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(99)70375-3     Document Type: Article

References (31)

1. Suffredini AF, Fromm RE, Parker MM, Brenner M, Kovacs JA, Wesley RA, et al. The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 1989;321:280-7.
2. Hegewisch S, Weh HJ, Hossfeid DK. TNF-induced cardiomyopathy. Lancet 1990;2:294-5.
3. Millar AB, Singer M, Meager A, Foley NM, Johnson NM, Rook GA. Tumor necrosis factor in bronchopulmonary secretions of patients with adult respiratory distress syndrome. Lancet 1989;2:712-3.
4. Gurevitch J, Frolkis I, Yuhas Y, Paz Y, Matsa M, Mohr R, et al. Tumor necrosis factor-alpha is released from the isolated heart undergoing ischemia and reperfusion. J Am Coll Cardiol 1996;28:247-52.
5. Aorre-Amione G, Kapadia S, Lee J, Durand JB, Bies RD, Young JB, et al. Tumor necrosis factor-a and tumor necrosis factor receptors in the failing human heart. Circulation 1996;93:704-11.
6. Gurevitch J, Frolkis I, Yuhas Y, Lifschitz-Mercer B, Berger E, Paz Y, et al. Anti-tumor necrosis factor-alpha improves myocardial recovery after ischemia and reperfusion. J Am Coll Cardiol 1997;30:1554-61.
7. Entman ML, Smith CW. Postreperfusion inflammation: a model for reaction to injury in cardiovascular disease. Cardiovasc Res 1994;28:1301-11.
8. Youker KA, Hawkins HK, Michael L. Molecular evidence for induction of intracellular adhesion molecule-1 (ICAM-1) in the viable border zone associated with ischemia-reperfusion injury of the dog heart. Circulation 1994;89:2736-46.
9. Nawroth PP, Stern DM. Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 1986;163:740-5.
10. Li DY, Weng S, Yang BC, Mehta JL. Angiotensin II augments anoxia-reoxygenation-mediated apoptosis of cultured human coronary endothelial cells: modulation by AT1 receptor antagonist losartan [abstract]. Circulation 1997;96(suppl 1):I-418.
11. Sheehan KC, Ruddle NH, Schreiber RD. Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors. J Immunol 1989;142:3884-93.
12. Kilgore KS, Park JL, Chi L, Musser JH, Luchessi BR. Reduction of myocardial infarct size in the rabbit by a carbohydrate analog of Sialyl Lewis X. J Cardiovasc Pharmacol Ther 1996;1:49-56.
13. Takahashi H, Harker L. Measurement of human endothelial cells in whole blood. Thromb Res 1983;31:1-12.
14. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-8.
15. Vilcek J, Lee TH. Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J Biol Chem 1991; 266:7313-6.
16. Kapadia S, Lee JS, Tone-Amione G, Mann DL. Endotoxin-induced TNFa gene and protein expression in adult feline myocardium. Am J Physiol 1995;37:H517-25.
17. Herskowitz A, Choi S, Ansari AA, Wesselingh S. Cytokine mRNA expression in post-ischemic/reperfused myocardium. Am J Pathol 1995;146:419-28.
18. Vaddi K, Nicolini FA, Mehta P, Mehta JL. Increased secretion of tumor necrosis factor-alpha and interferon-gamma by mononuclear leukocytes in patients with ischemic heart disease: relevance in superoxide anion generation. Circulation 1994;90:694-9.
19. Matsumori A, Yamada T, Suzuki H, Matoba Y, Sasayama S. Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J 1994;72:561-6.
20. Arbustini E, Grasso M, Diegoli M, Bramerio M, Foglieni AS, Albertario M, et al. Expression of tumor necrosis factor in human acute cardiac rejection: an immunohistochemical and immunoblotting study. Am J Pathol 1991;139:709-15.
21. Yokoyama T, Vaca L, Rossen RD, Durante W, Hazarika P, Mann DL. Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. J Clin Invest 1993;92:2303-12.
22. Murray D, Freeman GL. Tumor necrosis factor-a induces a biphasic effect on myocardial contractility in conscious dogs. Circ Res 1996:78:154-60.
23. Haught WH, Mansour M, Rothlein R, Kishimoto TK, Mainolfi EA, Hendricks JB,et al. Alterations in circulating intercellular adhesion molecule-1 and L-selection: further evidence for chronic inflammation in ischemic heart disease. Am Heart J 1996;132:1-6.
24. Barath P, Fishbein MC, Cao J. Tumor necrosis factor gene expression in human vascular intimal smooth muscle cells detected by in situ hybridization. Am J Pathol 1990;137:503-9.
25. Stern DM, Bank I, Nawroth PP. Self-regulation of procoagulant events on the endothelial cell surface. J Exp Med 1985;162:1223-35.
26. Medina R, Socher SH, Han JH. Interleukin 1, endotoxin or tumor necrosis factor (cachectin) enhance the level of plasminogen activator inhibitor messenger RNA in bovine aortic endothelial cells. Thromb Res 1989;54:41-52.
27. Mehta JL, Nicolini FA, Donnelly WH, Nichols WW. Platelet-leukocyte-endothelial interactions in coronary artery disease. Am J Cardiol 1992;69:1B-7B.
28. Murphy HS, Shayman JA, Till GO. Superoxide response of endothelial cells to C5a and TNF: divergent signal transduction pathways. Am J Physiol 1992;263:L51-9.
29. Pogrebniak HW, Matthews WA, Pass HI. Reactive oxygen species can amplify macrophage tumor necrosis factor production. Surgical Forum 1990;16:101-3.
30. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992;257:387-9.
31. Deswal A, Seta Y, Blosch CM, Mann DL. A phase I trial of tumor necrosis factor receptor (p75) fusion protein (TNPR:Fc) in patients with advanced heart failure [abstract]. Circulation 1997;96(suppl):I-323.